Cargando…

Multiomics Data Analysis and Identification of Immune-Related Prognostic Signatures With Potential Implications in Prognosis and Immune Checkpoint Blockade Therapy of Glioblastoma

BACKGROUND: In recent years, glioblastoma multiforme (GBM) has been a concern of many researchers, as it is one of the main drivers of cancer-related deaths worldwide. GBM in general usually does not responding well to immunotherapy due to its unique microenvironment. METHODS: To uncover any further...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ma, Shuai, Wang, Fang, Wang, Nan, Jin, Jiaqi, Ba, Yixu, Ji, Hang, Du, Jianyang, Hu, Shaoshan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Neurology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9165649/ https://www.ncbi.nlm.nih.gov/pubmed/35669882 http://dx.doi.org/10.3389/fneur.2022.886913

Ejemplares similares

Integrated analysis of genome-wide DNA methylation and cancer-associated fibroblasts identified prognostic biomarkers and immune checkpoint blockade in lower grade gliomas
por: Dong, Jiawei, et al.
Publicado: (2023)

Construction of Interferon-Gamma-Related Gene Signature to Characterize the Immune-Inflamed Phenotype of Glioblastoma and Predict Prognosis, Efficacy of Immunotherapy and Radiotherapy
por: Ji, Hang, et al.
Publicado: (2021)

Ferroptosis-Related Gene Contributes to Immunity, Stemness and Predicts Prognosis in Glioblastoma Multiforme
por: Dong, Jiawei, et al.
Publicado: (2022)

Recognition of Tumor-Associated Antigens and Immune Subtypes in Glioma for mRNA Vaccine Development
por: Ma, Shuai, et al.
Publicado: (2021)

Novel Immune-Related Gene-Based Signature Characterizing an Inflamed Microenvironment Predicts Prognosis and Radiotherapy Efficacy in Glioblastoma
por: Ji, Hang, et al.
Publicado: (2022)

5-Methylcytosine Related LncRNAs Reveal Immune Characteristics, Predict Prognosis and Oncology Treatment Outcome in Lower-Grade Gliomas
por: Zhang, Jiheng, et al.
Publicado: (2022)

Malignant Evaluation and Clinical Prognostic Values of m6A RNA Methylation Regulators in Glioblastoma
por: Du, Jianyang, et al.
Publicado: (2020)

A cuproptosis-related lncRNAs signature for prognosis, chemotherapy, and immune checkpoint blockade therapy of low-grade glioma
por: Yan, Xiuwei, et al.
Publicado: (2022)

Identification of Prognostic Model and Biomarkers for Cancer Stem Cell Characteristics in Glioblastoma by Network Analysis of Multi-Omics Data and Stemness Indices
por: Du, Jianyang, et al.
Publicado: (2020)

Treatment Progress of Immune Checkpoint Blockade Therapy for Glioblastoma
por: Zhang, Na, et al.
Publicado: (2020)

Extended Application of Genomic Selection to Screen Multi-Omics Data for the Development of Novel Pyroptosis-Immune Signatures and Predicting Immunotherapy of Glioma
por: Ma, Shuai, et al.
Publicado: (2022)

An immunomodulatory signature of responsiveness to immune checkpoint blockade therapy
por: Shen, Hongru, et al.
Publicado: (2020)

Characterization of the Ferroptosis-Related Genes for Prognosis and Immune Infiltration in Low-Grade Glioma
por: Yan, Xiuwei, et al.
Publicado: (2022)

A 2-Gene Signature Related to Interferon-Gamma Predicts Prognosis and Responsiveness to Immune Checkpoint Blockade of Glioma
por: Li, Yongzhe, et al.
Publicado: (2022)

An immune signature to predict the prognosis of ATRX-wildtype glioma patients and guide immune checkpoint blockade therapy
por: Cao, Wenpeng, et al.
Publicado: (2023)

Development of a T-cell activation-related module with predictive value for the prognosis and immune checkpoint blockade therapy response in glioblastoma
por: Yan, Zihao, et al.
Publicado: (2021)

TGF-β based risk model to predict the prognosis and immune features in glioblastoma
por: Liu, Hongchao, et al.
Publicado: (2023)

Development of an Immune-Related Prognostic Index Associated With Glioblastoma
por: Jiang, Zhengye, et al.
Publicado: (2021)

Immune checkpoint blockade in glioblastoma: from tumor heterogeneity to personalized treatment
por: Arrieta, Víctor A., et al.
Publicado: (2023)

A specific immune signature for predicting the prognosis of glioma patients with IDH1-mutation and guiding immune checkpoint blockade therapy
por: Zeng, Zhirui, et al.
Publicado: (2022)

Characterization of a lactate metabolism-related signature for evaluation of immune features and prediction prognosis in glioma
por: Wu, Zhiqiang, et al.
Publicado: (2023)

Radiomics features from perihematomal edema for prediction of prognosis in the patients with basal ganglia hemorrhage
por: Zhou, Peng, et al.
Publicado: (2022)

Corticosteroids and immune checkpoint blockade
por: Min, Le, et al.
Publicado: (2015)

Immune checkpoint blockade in HIV
por: Gubser, Celine, et al.
Publicado: (2022)

Microbial mechanisms to improve immune checkpoint blockade responsiveness
por: Griffin, Matthew E., et al.
Publicado: (2022)

Combination of DNA Vaccine and Immune Checkpoint Blockades Improves the Immune Response in an Orthotopic Unresectable Glioblastoma Model
por: Bausart, Mathilde, et al.
Publicado: (2022)

Association Between Hearing Characteristics/Prognosis and Vestibular Function in Sudden Sensorineural Hearing Loss With Vertigo
por: Wang, Yixu, et al.
Publicado: (2020)

Immune Checkpoint Inhibitor-Induced Myasthenia Gravis
por: Huang, Yi-Te, et al.
Publicado: (2020)

Construction and validation of a glioblastoma prognostic model based on immune-related genes
por: Huang, Kate, et al.
Publicado: (2022)

Novel tumor necrosis factor-related long non-coding RNAs signature for risk stratification and prognosis in glioblastoma
por: Long, Shengrong, et al.
Publicado: (2023)

4-1BB Agonism as a strategy to license immune checkpoint blockade in glioblastoma
por: Woroniecka, Karolina, et al.
Publicado: (2020)

The Prognosis and Immune Checkpoint Blockade Efficacy Prediction of Tumor-Infiltrating Immune Cells in Lung Cancer
por: Liu, Xiangzheng, et al.
Publicado: (2021)

Predictive biomarkers for tumor immune checkpoint blockade
por: Tong, Mengting, et al.
Publicado: (2018)

Immune checkpoint blockade in ovarian cancer
por: Weiss, Lukas, et al.
Publicado: (2016)

Hallmarks of response to immune checkpoint blockade
por: Cogdill, Alexandria P, et al.
Publicado: (2017)

Immune-Checkpoint Blockade Therapy in Lymphoma
por: Kuzume, Ayumi, et al.
Publicado: (2020)

Activation of phagocytosis by immune checkpoint blockade
por: Li, Chia-Wei, et al.
Publicado: (2018)

Neutrophils in the era of immune checkpoint blockade
por: Faget, Julien, et al.
Publicado: (2021)

Predictive value of PIMREG in the prognosis and response to immune checkpoint blockade of glioma patients
por: Zhu, Hua, et al.
Publicado: (2022)

A new immune checkpoint-associated nine-gene signature for prognostic prediction of glioblastoma
por: Jin, Xiao, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_r5g5k1ntamas6ihb7befgd29fq